Life Sciences | China, Life Sciences + Healthcare, China, Intellectual Property Litigation, and Technology Transactions
On September 23, 2019, China National Intellectual Property Administration (“CNIPA”) announced its proposed amendments to China’s Guideline on Patent Examination (the “Guideline”), which is the counterpart of the Manual of Patent Examining Procedure in the U.S. The proposed amendments will become effective November 1, 2019.
Read the full article.
©1996-2019 Morrison & Foerster LLP. All rights reserved.